Delivery Order SPE2DB22D9353-SPE2DB24FX2DG

Award Date 9/6/24
Potential Completion Date 9/27/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,254.96 firm fixed-price contract is for the procurement of PERJETA 420 MG/14 ML VIAL 14ML, a specialty oncology drug. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,529.76 firm fixed-price delivery order covers the supply of 4565730524 - PERJETA 420 MG/14 ML VIAL 14ML, with a period of performance through September 26, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $34,039.68 and has an ultimate completion date of July 19, 2024. The contract is for the delivery of the pharmaceutical product PERJETA 420 MG/14 ML VIAL 14ML, with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,529.76 firm-fixed-price contract is for the delivery of 4564676682 - PERJETA 420 MG/14 ML VIAL 14ML and has a completion date of June 10, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, for the provision of a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $78,783.00 firm fixed-price delivery order is for the supply of 4556749427 PERJETA 420 MG/14 ML VIAL 14ML to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $45,572.70 and an ultimate completion date of March 17, 2025. The award is for the delivery of 4567394636 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,039.68 firm fixed-price contract is for the supply of 4566210981 PERJETA 420 MG/14 ML VIAL 14ML, a specialized oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This federal contract award, valued at $12,764.88, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4565242595 PERJETA 420 MG/14 ML VIAL 14ML, with an ultimate completion date of August 12, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $25,529.76, is for the delivery of a specialty oncology drug, PERJETA 420 MG/14 ML VIAL 14ML, with a period of performance through July 22, 2024. The award is part of a larger indefinite delivery contract (IDC) vehicle, SPE2DB, held by DMS Pharmaceutical Group with...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract valued at $8,509.92 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4566529142 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized pharmaceutical product, with a performance period through December 12, 2024. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB24FX2DG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order, with a firm fixed price, to supply 4565763622 PERJETA 420 MG/14 ML VIAL 14ML. The contract has a ceiling value of $21,274.80 and a completion date of September 27, 2024.

The contract is part of a larger indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a wide range of pharmaceutical items, including both common medications and specialized drugs, to support the medical supply needs of various Department of Defense healthcare facilities worldwide. The contract does not have a set-aside designation.

Generated 12/6/24, 9:29 AM